chrX-134486539-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_000194.3(HPRT1):c.384+9C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.000019 ( 0 hom., 0 hem., cov: 20)
Exomes 𝑓: 0.000040 ( 0 hom. 11 hem. )
Consequence
HPRT1
NM_000194.3 intron
NM_000194.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.45
Genes affected
HPRT1 (HGNC:5157): (hypoxanthine phosphoribosyltransferase 1) The protein encoded by this gene is a transferase, which catalyzes conversion of hypoxanthine to inosine monophosphate and guanine to guanosine monophosphate via transfer of the 5-phosphoribosyl group from 5-phosphoribosyl 1-pyrophosphate. This enzyme plays a central role in the generation of purine nucleotides through the purine salvage pathway. Mutations in this gene result in Lesch-Nyhan syndrome or gout.[provided by RefSeq, Jun 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.51).
BP6
Variant X-134486539-C-T is Benign according to our data. Variant chrX-134486539-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 435446.We mark this variant Likely_benign, oryginal submissions are: {Benign=1, Uncertain_significance=1}.
BS2
High Hemizygotes in GnomAdExome4 at 11 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HPRT1 | NM_000194.3 | c.384+9C>T | intron_variant | ENST00000298556.8 | NP_000185.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HPRT1 | ENST00000298556.8 | c.384+9C>T | intron_variant | 1 | NM_000194.3 | ENSP00000298556 | P1 | |||
HPRT1 | ENST00000462974.5 | n.542+9C>T | intron_variant, non_coding_transcript_variant | 3 | ||||||
HPRT1 | ENST00000475720.1 | n.342+9C>T | intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000189 AC: 2AN: 105897Hom.: 0 Cov.: 20 AF XY: 0.00 AC XY: 0AN XY: 29325
GnomAD3 genomes
AF:
AC:
2
AN:
105897
Hom.:
Cov.:
20
AF XY:
AC XY:
0
AN XY:
29325
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000396 AC: 7AN: 176564Hom.: 0 AF XY: 0.0000648 AC XY: 4AN XY: 61742
GnomAD3 exomes
AF:
AC:
7
AN:
176564
Hom.:
AF XY:
AC XY:
4
AN XY:
61742
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000402 AC: 39AN: 970142Hom.: 0 Cov.: 18 AF XY: 0.0000403 AC XY: 11AN XY: 272848
GnomAD4 exome
AF:
AC:
39
AN:
970142
Hom.:
Cov.:
18
AF XY:
AC XY:
11
AN XY:
272848
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000189 AC: 2AN: 105897Hom.: 0 Cov.: 20 AF XY: 0.00 AC XY: 0AN XY: 29325
GnomAD4 genome
AF:
AC:
2
AN:
105897
Hom.:
Cov.:
20
AF XY:
AC XY:
0
AN XY:
29325
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Apr 25, 2016 | - - |
Lesch-Nyhan syndrome;C0268117:Partial hypoxanthine-guanine phosphoribosyltransferase deficiency Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 16, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at